[2020], which suggests a significant difference in serum GAL-3 levels between PTC patients with LNM and those without, our results demonstrated that the level of GAL-3 was highly significant in the serum of LNM patients compared with no metastasis patients ( 28 ).
← all excerpts
The diagnostic efficacy of serum galectin-3 and other markers in papillary thyroid carcinoma.
1
—
—